MarketPeel
Insider Trading Intelligence
Pricing
…
JF

John David Finley

PALI
CEO, CFO, DIRECTOR · PALISADE BIO, INC. · CIK 0001851034
FILING MIX · LIFETIME70%/30%
BUYS
72
SELLS
31
TOTAL VALUE
$435.5K
COMPANIES
1
ACTIVE SINCE
Apr 2021
HOLDINGS NOW
217,688
AVG SELL PX
$2.07
TRADE KIND
SHOWING 103 / 103
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by John David Finley, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+33.33%-5.93%-0.77%-5.16%-4.84%—
14d15+26.67%-6.48%-1.83%-4.65%-7.79%—
30d15+13.33%-13.69%-3.05%-10.64%-14.38%—
60d15+20.00%-22.17%-2.39%-19.78%-23.87%—
90d15+13.33%-28.65%+0.95%-29.60%-32.28%—
180d15(1 pending)+0.00%-63.34%+2.75%-66.08%-70.53%—
1y15(1 pending)+0.00%-86.55%+8.70%-95.25%-96.34%—
2y15(1 pending)+0.00%-92.06%+31.73%-123.79%-129.63%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PALI · 217,688 shares · as of Jul 7, 2026
02,294,8504,589,7006,884,5509,179,40020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 72 buys / 31 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO
133$0.70$93217,688Jul 7, 2026Jul 8, 2026 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO
133——0Jul 7, 2026Jul 8, 2026 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO
146,798$2.07$303.3K217,555Jul 7, 2026Jul 8, 2026 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO
335,167——364,353Jul 6, 2026Jul 8, 2026 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO
335,167——1,675,833Jul 6, 2026Jul 8, 2026 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO
3,896$1.75$6.8K27,353Feb 12, 2026Feb 13, 2026 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO
13,333——31,249Feb 11, 2026Feb 13, 2026 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO
13,333——26,667Feb 11, 2026Feb 13, 2026 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
2,011,000——2,011,000Feb 9, 2026Feb 11, 2026 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
9,179,400——9,179,400Oct 6, 2025Oct 8, 2025 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
323,400——323,400Sep 4, 2025Sep 5, 2025 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Feb 11, 2025Feb 13, 2025 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
47,000——47,000Feb 11, 2025Feb 13, 2025 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
607$4.76$2.9K13,472May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
1,622——10,059May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
2,111——0May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
1,622——0May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
467$4.76$2.2K9,592May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
2,111——14,079May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
3,335——0May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
3,335——12,927May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
959$4.76$4.6K11,968May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
1,000$4.81$4.8K8,437May 24, 2024May 28, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
666$4.97$3.3K7,437May 20, 2024May 22, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
67$8.46$5676,621May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
232——6,688May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
211——6,832May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
211——2,111May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
61$8.46$5166,771May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
232——1,622May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
5,558——50,025Mar 11, 2024Mar 12, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
5,558——96,849Mar 11, 2024Mar 12, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
10,000$0.47$4.7K84,649Feb 6, 2024Feb 7, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
3,475——27,800Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
3,167——91,291Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
3,167——34,833Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
3,475——88,124Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
10,000$0.56$5.6K74,649Jan 31, 2024Feb 1, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
1,309——0Jan 3, 2024Jan 5, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
1,309——64,649Jan 3, 2024Jan 5, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
5,559——63,340Dec 11, 2023Dec 19, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
5,559——55,583Dec 11, 2023Dec 19, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
45,000——45,000Nov 21, 2023Nov 24, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
38,000——38,000Nov 21, 2023Nov 24, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
10,000$0.51$5.1K57,781Nov 20, 2023Nov 24, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
3,475——31,275Nov 6, 2023Nov 8, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
3,475——47,781Nov 6, 2023Nov 8, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
397$0.55$21844,306Oct 4, 2023Oct 5, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
1,309——44,703Oct 3, 2023Oct 5, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
1,309——1,309Oct 3, 2023Oct 5, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
15,000$0.54$8.1K43,394Sep 27, 2023Sep 29, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
15,000$0.66$9.8K28,394Sep 13, 2023Sep 14, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
1,792$0.66$1.2K13,394Sep 12, 2023Sep 13, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
5,558——61,142Sep 11, 2023Sep 13, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
5,558——15,186Sep 11, 2023Sep 13, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
1,040$0.70$7289,628Aug 11, 2023Aug 14, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
3,475——11,057Aug 6, 2023Aug 14, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
3,475——34,750Aug 6, 2023Aug 14, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
1,050$1.54$1.6K6,273Jun 13, 2023Jun 14, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
3,475——38,225Jun 12, 2023Jun 14, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
3,475——7,323Jun 12, 2023Jun 14, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
148,500——148,500Jun 11, 2023Jun 13, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
66,700——66,700Jun 11, 2023Jun 13, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
435$2.01$8743,848Apr 3, 2023Apr 5, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
1,309——4,283Apr 3, 2023Apr 5, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
1,309——3,927Apr 3, 2023Apr 5, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
41,700——41,700Feb 6, 2023Feb 8, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
32,500——32,500Feb 6, 2023Feb 8, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
57,200——57,200Feb 6, 2023Feb 8, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
5,236——5,236Jan 3, 2023Jan 6, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
19,481.242$0.14$2.8K148,727.242Sep 1, 2022Sep 2, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
7,350$0.16$1.2K129,246Aug 23, 2022Aug 25, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
100,000$0.25$25.0K121,896Aug 16, 2022Aug 18, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
100,000——100,000Aug 16, 2022Aug 18, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
100,000——100,000Aug 16, 2022Aug 18, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
12,545——38,867Apr 29, 2022May 2, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
7,500$1.09$8.2K21,896Mar 24, 2022Mar 24, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
64,800——64,800Feb 17, 2022Feb 22, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
178,091——178,091Nov 18, 2021Feb 10, 2022 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
2,000$2.44$4.9K14,396Sep 21, 2021Sep 22, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
1,600$2.63$4.2K3,996Aug 27, 2021Aug 30, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Financial Officer
8,400$2.65$22.3K12,396Aug 27, 2021Aug 30, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
516——516Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
293——293Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
95——95Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
27——27Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
19,033——19,033Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
9,702——9,702Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
26,322——26,322Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
7,952——7,952Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
14,708——14,708Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
2,595——2,595Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
9,516——9,516Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
49——49Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
10,418——10,418Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
5,662——5,662Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
51——51Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
40——40Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
2,396——2,396Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
339——339Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
52,068——52,068Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
503——503Apr 27, 2021Apr 29, 2021 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
325——325Apr 27, 2021Apr 29, 2021 ↗View →
Other insiders · PALI
Loading peer insiders…
About this filer
CIK 0001851034
ROLE
CEO, CFO, Director
PRIMARY
PALI
COMPANIES
1
ACTIVE SINCE
Apr 2021
MARKETPEEL · /INSIDER/0001851034DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback